Compare IOVA & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | CMP |
|---|---|---|
| Founded | 2007 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.0B |
| IPO Year | 2008 | 2003 |
| Metric | IOVA | CMP |
|---|---|---|
| Price | $3.97 | $21.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $9.11 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 16.9M | 379.5K |
| Earning Date | 05-25-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | $49.14 | N/A |
| Revenue Next Year | $51.69 | $1.85 |
| P/E Ratio | ★ N/A | $52.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.64 | $8.60 |
| 52 Week High | $5.63 | $27.00 |
| Indicator | IOVA | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 52.57 | 38.19 |
| Support Level | $1.99 | $20.58 |
| Resistance Level | $4.34 | $26.40 |
| Average True Range (ATR) | 0.50 | 1.14 |
| MACD | -0.00 | -0.31 |
| Stochastic Oscillator | 28.72 | 12.72 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.